These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 364653)

  • 21. Oral choline in tardive dyskinesia.
    Ray R; Ramakrishnan N; Rao BS
    Indian J Med Res; 1982 Oct; 76():628-31. PubMed ID: 7152571
    [No Abstract]   [Full Text] [Related]  

  • 22. [Clinical double blind study of a geriatric combination, UCB 8262 or Geratar].
    Paquay J; Arnould F; Burton P; Piersotte J; Puffet E; Tinant M
    Acta Neurol Psychiatr Belg; 1965 Sep; 65(9):711-9. PubMed ID: 4954635
    [No Abstract]   [Full Text] [Related]  

  • 23. Choline and lecithin for the treatment of tardive dyskinesia [proceedings].
    Gelenberg AJ
    Psychopharmacol Bull; 1979 Apr; 15(2):74-5. PubMed ID: 432384
    [No Abstract]   [Full Text] [Related]  

  • 24. Choline and lecithin administration to patients with tardive dyskinesia.
    Growdon JH; Gelenberg AJ
    Trans Am Neurol Assoc; 1978; 103():95-9. PubMed ID: 757093
    [No Abstract]   [Full Text] [Related]  

  • 25. Treatment of tardive dyskinesia with choline and tetrabenazine.
    Snell AP; Cleary M; Sambrook M
    Postgrad Med J; 1980 Sep; 56(659):663-4. PubMed ID: 7465478
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative efficacy of risperidone versus haloperidol on behavioural and psychological symptoms of dementia.
    Suh GH; Greenspan AJ; Choi SK
    Int J Geriatr Psychiatry; 2007 May; 22(5):494-5. PubMed ID: 17471597
    [No Abstract]   [Full Text] [Related]  

  • 27. Choline chloride in the treatment of Huntington's disease and tardive dyskinesia: a preliminary report.
    Davis KL; Berger PA; Hollister LE; Simonton SC
    Psychopharmacol Bull; 1977 Jul; 13(3):37-8. PubMed ID: 142261
    [No Abstract]   [Full Text] [Related]  

  • 28. Double-blind study of lecithin in the treatment of persistent tardive dyskinesia.
    Pérez-Cruet J; Menéndez I; Alvarez-Ghersi J; Falcón JR; Valderrábano O; Castro-Urrutia EC; Ifarraguerri C; Pérez LL
    Bol Asoc Med P R; 1981 Nov; 73(11):531-7. PubMed ID: 6121562
    [No Abstract]   [Full Text] [Related]  

  • 29. Choline in treatment of ataxia.
    Clayton MR
    Med J Aust; 1980 Oct; 2(7):402-3. PubMed ID: 7453616
    [No Abstract]   [Full Text] [Related]  

  • 30. Naloxone may be beneficial in the treatment of tardive dyskinesia.
    Blum I; Munitz H; Shalev A; Roberts E
    Clin Neuropharmacol; 1984; 7(3):265-7. PubMed ID: 6386154
    [No Abstract]   [Full Text] [Related]  

  • 31. Diltiazem for tardive dyskinesia.
    Ross JL; Mackenzie TB; Hanson DR; Charles CR
    Lancet; 1987 Jan; 1(8527):268. PubMed ID: 2880079
    [No Abstract]   [Full Text] [Related]  

  • 32. Diltiazem for tardive dyskinesia.
    Leys D; Vermersch P; Danel T; Comayras S; Goudemand M; Caron J; Petit H
    Lancet; 1988 Jan; 1(8579):250-1. PubMed ID: 2893079
    [No Abstract]   [Full Text] [Related]  

  • 33. [A double-blind study of the effect of L-dopa in psychotic patients with tardive dyskinesia].
    Karniol IG; Giampietro AC; Moura DS; Vilela WA; Oliveira MA; Zuardi AW
    Acta Psiquiatr Psicol Am Lat; 1983 Dec; 29(4):261-6. PubMed ID: 6369888
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Emerging treatments: replacement therapy with choline or lecithin in neurological diseases.
    Barbeau A
    Can J Neurol Sci; 1978 Feb; 5(1):157-60. PubMed ID: 148319
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Effectiveness of piracetam in tardive dyskinesia - double-blind cross-over controlled trial with a placebo].
    Kabes J; Sikora J; Starý O; Pisvejc J; Hanzlícek L
    Cesk Psychiatr; 1983 Oct; 79(5):339-45. PubMed ID: 6357509
    [No Abstract]   [Full Text] [Related]  

  • 36. Biochemical substrates of mental disturbances in Parkinson's disease.
    Agid Y; Ruberg M; Dubois B; Javoy-Agid F
    Adv Neurol; 1984; 40():211-8. PubMed ID: 6695597
    [No Abstract]   [Full Text] [Related]  

  • 37. Psychiatry.
    Freedman DX
    JAMA; 1978 Feb; 239(6):510-2. PubMed ID: 23443
    [No Abstract]   [Full Text] [Related]  

  • 38. Introduction: movement disorders in psychiatry, specifically to drug-induced dyskinesias.
    Höschl C
    Pharmacopsychiatry; 2000 Sep; 33 Suppl 1():1-2. PubMed ID: 11072760
    [No Abstract]   [Full Text] [Related]  

  • 39. Dietary influences on the synthesis of neurotransmitters in the brain.
    Growdon JH; Wurtman RJ
    Nutr Rev; 1979 May; 37(5):129-36. PubMed ID: 40170
    [No Abstract]   [Full Text] [Related]  

  • 40. Tardive dyskinesia: clinical, biological, and pharmacological perspectives.
    Berger PA; Rexroth K
    Schizophr Bull; 1980; 6(1):102-16. PubMed ID: 6102788
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.